vimarsana.com

Page 6 - கொள்ளை கிரென்ஃபெல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Highly-infectious mutant Indian Covid-19 strain wreaking havoc in Melbourne could lead to lockdown

A concerning coronavirus cluster in Melbourne has now climbed to nine cases Contact tracers are scrambling to track down the mystery link of infection Latest cases are of the double mutant Indian strain, which is hyper-infectious Three infected cases over-50 had not been vaccinated, despite being eligible There are 43 venues on the outbreak s exposure list as of Wednesday morning  Alert issued after infected case attended the AFL game at the MCG on Sunday

CSIRO publishes preclinical study results for Oxford-AstraZeneca vaccine

CSIRO CSIRO, Australia’s national science agency, has published the peer-reviewed results of its independent preclinical evaluation of the University of Oxford-AstraZeneca COVID-19 vaccine in an animal model, conducted in early 2020. Peer-reviewed results from last year’s preclinical evaluation of the University of Oxford-AstraZeneca COVID-19 vaccine have been published today in the scientific journal npj Vaccines. CSIRO, Australia’s national science agency, conducted the independent preclinical evaluation of the vaccine in an animal model in early 2020. The study was conducted in partnership with the Coalition for Epidemic Preparedness Innovations (CEPI). Quality assured and quality-controlled data was shared last year with CEPI and the University of Oxford to support human clinical trials.

COVID vaccines: where the bloody hell are we?

COVID vaccines: where the bloody hell are we? New AstraZeneca advice puts a spanner in the works, so what are our alternatives? Australia’s vaccine rollout program is now being overhauled due to new recommendations regarding the AstraZeneca vaccine. Based on the advice of the Australian Technical Advisory Group on Immunisation (ATAGI), the Federal Government has recommended that people under 50 preferentially receive the Pfizer vaccine over AstraZeneca. This follows similar decisions made by regulators in Germany, Norway, Canada, the UK and other countries where the vaccine is being administered. The recommendation comes after reports of serious side effects of blood clotting disorders, mostly associated with younger people.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.